Institutional investors purchased a net $582.3 thousand shares of ABMD during the quarter ended December 2017 and now own 87.62% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 568.2 Thousand shares of Abiomed Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 479.4 Thousand shares of Abiomed Inc
MARSHALL WACE NORTH AMERICA LP Bought 346.8 Thousand shares of Abiomed Inc